Fast-Acting Black-Phosphorus-Assisted Depression Therapy with Low Toxicity

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Depression is a prevalent mental health disorder requiring effective therapeutic strategies.
• Current antidepressant treatments, such as Fluoxetine, can have limitations including prolonged therapy duration and side effects.
• Novel drug delivery systems are needed to enhance therapeutic efficacy and patient outcomes.

Purpose of the Study:

• To develop and evaluate a black phosphorus (BP)-nanosheet-based drug delivery system for Fluoxetine (Flu).
• To investigate the efficacy of the BP-Flu system, activated by near-infrared (NIR) light, in reducing depression therapy time.
• To assess the impact of the BP-Flu system on the inherent biotoxicity of Fluoxetine.

Main Methods:

• Synthesis of black phosphorus (BP) nanosheets.
• Encapsulation of Fluoxetine (Flu) within the BP nanosheets to form the BP-Flu system.
• In vitro and in vivo evaluations including behavioral, biochemical, and electrophysiological analyses.
• Irradiation of the BP-Flu system with near-infrared light (808 nm) to trigger drug release and therapeutic effects.

Main Results:

• Successful synthesis of a black phosphorus nanosheet drug delivery system loaded with Fluoxetine.
• BP-Flu, upon 808 nm NIR light irradiation, significantly reduced the time required for depression therapy in preclinical models.
• The BP-Flu system demonstrated an alleviation of the inherent biotoxicity associated with Fluoxetine treatment.
• Electrophysiological and biochemical analyses supported the therapeutic efficacy and reduced toxicity.

Conclusions:

• The developed black phosphorus-Fluoxetine (BP-Flu) system offers a promising photothermal-triggered therapeutic approach for depression.
• NIR light activation of the BP-Flu system enhances antidepressant efficacy and mitigates Fluoxetine's adverse effects.
• This nanodrug delivery platform holds potential for improved depression management with reduced toxicity.